Ghost Tree Capital, LLC Poly Pid Ltd. Transaction History

Ghost Tree Capital, LLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2020 Nov 16, 2020	SELL	$11.0 - $17.33 $1.1 Million - $1.73 Million	-100,000 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$18.03 - $19.0 $1.8 Million - $1.9 Million	100,000 New	100,000 $1.8 Million

Ticker PYPD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 19,551,200
Market Cap $64.5M
Description
PolyPid Ltd., a late-stage biopharma company, develops, manufactures, and commercializes products based on polymer-lipid encapsulation matrix (PLEX) platform to address unmet medical needs. Its lead product candidate is D-PLEX100, which is in Phase III clinical trial for the prevention of sternal (bone) surgical site infections (SSIs), as well a...

Get notified when there are updates to the investment portfolio of Ghost Tree Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ghost Tree Capital, LLC with notifications on news.